Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma

Thyroid ◽  
2017 ◽  
Vol 27 (7) ◽  
pp. 944-952 ◽  
Author(s):  
Zao Yang ◽  
Jose Flores ◽  
Sanford Katz ◽  
Cherie-Ann Nathan ◽  
Vikas Mehta
Keyword(s):  
Thyroid Carcinoma ◽  
Radioactive Iodine ◽  
Stage Iv ◽  
Differentiated Thyroid Carcinoma ◽  
External Beam Radiation ◽  
Survival Outcomes ◽  
External Beam ◽  
Beam Radiation

scholarly journals Targeted Therapy in Management of Advanced Follicular Thyroid Carcinoma

2020 ◽  
pp. 1-3
Author(s):  
Leong Tung Ong ◽  
Keyword(s):  
Targeted Therapy ◽  
Thyroid Carcinoma ◽  
Radioactive Iodine ◽  
Kinase Inhibitors ◽  
Follicular Thyroid Carcinoma ◽  
Therapeutic Option ◽  
External Beam Radiation ◽  
Beam Radiation ◽  
Thyroid Glands ◽  
Common Malignancy

Follicular thyroid carcinoma (FTC) is the second most common malignancy involving the thyroid glands. Early stages of FTC are managed with total thyroidectomy followed by 131I ablation and external beam radiation therapy. Targeted therapy with tyrosine kinase inhibitors (TKIs) is an essential therapeutic option for the management of advanced cases of radioactive iodine refractory. This review will investigate the clinical data for the therapeutic use of targeted therapy in advanced FTC and compare the efficacy of different targeted therapy used in managing the patients

Sign in / Sign up

Export Citation Format

Share Document